News | Radiology Business | October 25, 2018

Principal investigator of two landmark mammography trials will identify clinical and socioeconomic research opportunities for ACR

Etta Pisano Named American College of Radiology Chief Research Officer

October 25, 2018 — Breast imaging research pioneer Etta Pisano, M.D., FACR, has been named chief research officer (CRO) of the American College of Radiology. Pisano is the first woman to hold this ACR position. She previously served as chief science officer (CSO) solely for of the ACR Center for Research and Innovation (CRI).

“Dr. Pisano is a giant in the clinical research community. She will identify clinical and socioeconomic research opportunities that can advance the practice of radiology and improve patient care. We are proud to have her as chief research officer for the entire College which will allow us to tap her talents and experience across the ACR,” said William T. Thorwarth, M.D., FACR, chief executive officer of the American College of Radiology.  

Pisano may be best known for leading landmark clinical research trials. She is principal investigator for the Tomosynthesis Mammographic Imaging Screening Trial (TMIST). Involving nearly 165,000 women, TMIST compares standard digital mammography (2-D) to digital breast tomosynthesis (DBT) to determine if DBT is more effective at reducing advanced breast cancers. TMIST will create the world’s largest aggregation of data, images and biospecimens arising from a clinical research trial.

Pisano previously led the Digital Mammography Screening Trial (DMIST) — which accrued 49,528 women to compare effectiveness of digital mammography to film mammography. DMIST results, published in the New England Journal of Medicine in 2005,1 dramatically changed breast cancer screening guidelines and reimbursement.

For more information: www.acr.org

Reference

1. Pisano E.D., Gatsonis C., Hendrick E., et al. Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening. New England Journal of Medicine, Oct. 27, 2005. DOI: 10.1056/NEJMoa052911


Related Content

News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Mammography

June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy ...

Time June 30, 2026
arrow
News | Interventional Radiology

June 25, 2026 — Radiologists performing no interventional radiology-related (IR-related) work increased from one-third ...

Time June 25, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
News | Artificial Intelligence

June 15, 2026 — HOPPR recently announced that HOPPR AI Foundry is now available in AWS Marketplace. The availability ...

Time June 19, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

June 9, 2026 — An investigator at the Icahn School of Medicine at Mount Sinai has received international recognition for ...

Time June 15, 2026
arrow
News | Women's Health

June 2, 2026 — Results of an American College of Radiology-managed retrospective study involving 110,000 women presented ...

Time June 02, 2026
arrow
News | Ultrasound Imaging

May 26, 2026 — A soft, wearable ultrasound patch that can continuously monitor a fetus for hours at a time — and it can ...

Time May 27, 2026
arrow
News

May 21, 2026 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 22, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
Subscribe Now